Overview

Open-Label Crossover Study Comparing CTP-543 to Jakafi®

Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
This study will assess the metabolite and pharmacokinetic (PK) profile of a single dose of CTP-543 compared to a single dose of Jakafi® in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Concert Pharmaceuticals